Literature DB >> 10561455

An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.

J Burchell1, R Poulsom, A Hanby, C Whitehouse, L Cooper, H Clausen, D Miles, J Taylor-Papadimitriou.   

Abstract

The MUC1 mucin is expressed on the luminal surface of most simple epithelial cells but in carcinomas, especially those of the breast and ovary, MUC1 is upregulated and aberrantly glycosylated. MUC1 contains a large amount of O-linked glycans which, in the mucin expressed by normal mammary epithelial cells, consist mainly of core 2 based structures carrying polylactosamine chains. However, the mucin expressed by breast carcinomas has shorter side-chains, often consisting of sialylated core 1 (Galbeta1-3GalNAc). in situ hybridization of primary breast tissue showed that a sialyltransferase (ST3Gal I), responsible for adding sialic acid to core 1 thereby terminating chain extension, is elevated in primary breast carcinomas when compared to normal or benign tissue. Furthermore, the level of mRNA expression encoding ST3Gal I is correlated to the intensity of staining seen with the antibody SM3, which specifically recognises underglycosylated, tumour associated MUC1. Thus, the aberrant glycosylation of MUC1 seen in breast carcinomas appears to be due, at least in part, to the elevation of ST3Gal I.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561455     DOI: 10.1093/glycob/9.12.1307

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  57 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Galectin-1 binds mucin in human trophoblast.

Authors:  Zanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Miloš Petronijević; Svetlana Vrzić-Petronijević; Snežana Golubović; Ljiljana Vićovac
Journal:  Histochem Cell Biol       Date:  2014-05-23       Impact factor: 4.304

3.  Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.

Authors:  Mariana Silva; Ronald Kam Fai Fung; Conor Brian Donnelly; Paula Alexandra Videira; Robert Sackstein
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

4.  Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines.

Authors:  Krajang Talabnin; Chutima Talabnin; Mayumi Ishihara; Parastoo Azadi; Sopit Wongkham; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

5.  Organizational interplay of Golgi N-glycosyltransferases involves organelle microenvironment-dependent transitions between enzyme homo- and heteromers.

Authors:  Antti Hassinen; Sakari Kellokumpu
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

6.  Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.

Authors:  Shilpa A Patil; Wiam Bshara; Carl Morrison; E V Chandrasekaran; Khushi L Matta; Sriram Neelamegham
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 7.  Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Authors:  Penelope M Drake; Wonryeon Cho; Bensheng Li; Akraporn Prakobphol; Eric Johansen; N Leigh Anderson; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

8.  Glycosylation potential of human prostate cancer cell lines.

Authors:  Yin Gao; Vishwanath B Chachadi; Pi-Wan Cheng; Inka Brockhausen
Journal:  Glycoconj J       Date:  2012-07-28       Impact factor: 2.916

Review 9.  Galectin-Binding O-Glycosylations as Regulators of Malignancy.

Authors:  Charles J Dimitroff
Journal:  Cancer Res       Date:  2015-07-29       Impact factor: 12.701

10.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.